a retrospective analysis of data collected over a 17-year period on outcomes in patients who underwent GKS for large VSs. We report treatment outcomes and analyze potentially important factors and their relationships to the duration of tumor swelling, as well as compare strategies for treating large VSs.
Methods

Patient Population
We reviewed a consecutive series of 513 patients who underwent GKS to treat a VS between March 1993 and October 2009. At least 1 year of data from regularly scheduled, follow-up MR imaging studies was available in 399 (77.8%) of these patients. Twenty-one of the 399 patients had presented with a large VS-one whose diameter was > 3 cm-and these patients form the population of interest in this study. The demographic features of these 21 patients are summarized in Table 1 . The mean age of patients harboring a large VS was 49.5 years, and there was a female predominance (57.1%) in this group. Microsurgical resection had been performed previously in 14 patients (66.7%). The mean tumor volume in this group of patients was 17.3 cm 3 (range 12.7-25.2 cm 3 ) based on calculations from MR imaging studies (Table 2) .
Characteristics of MR Images Before Radiosurgery
Preoperative MR images were carefully reviewed, and findings of solid and cystic tumor components, brainstem compression, and bone invasion were recorded (Fig.  1) . In reviewing these MR images, we found that tumors that displayed a high signal intensity on T2-weighted MR images tended to respond better to treatment than those that did not. In the literature, it has been reported that VSs that exhibit a high signal intensity on T2-weighted MR images are associated with a high-fluid and rich-loosetissue content, that is, the Antoni Type B component. 7 We
propose that the T/BS T2 ratio (in which T = whole tumor volume, BS = brainstem at the internal acoustic meatus level, and T2 = T2-weighted image) may be a crucial variable in the tumor response to radiosurgery. Because signal intensity alters when parameters in each MR study are changed, we used the "normalized T/BS T2 ratio" instead of the straight value of signal intensity for a comparison.
The mean signal intensity of the tumor on T2-weighted images was obtained by hand drawing the ROI, slice by slice, on the picture archiving and communication system (SmartIRIS, Helpera), which encompasses the entire tumor volume. The signal intensity of the brainstem on T2-weighted images was obtained by referring to a 1-cm circular ROI at the center of the brainstem on the slice obtained at the level of the internal acoustic meatus. As shown in Fig. 2 , the T/BS T2 ratio was then obtained.
Gamma Knife Surgery
Radiosurgery was performed using a Leksell Gamma Knife model B unit between 1993 and 2006 and a model C unit (Elekta AB) thereafter. Radiosurgical data are summarized in Table 2 . The margin dose was prescribed at an isodose level of 50%-60% (median 57%). In this patient series, only 1 patient harboring a large VS received a high-margin dose (14 Gy); the remaining patients received a mean margin dose of 11.9 Gy (range 11-14 Gy). No recognizable portion of the facial nerve received > 13 Gy, and the trigeminal nerve did not receive > 15 Gy. The average mean dose to the targeted tumor volume was 15.7 Gy (range of mean doses 15-17.5 Gy). Multiple-shot dose planning from 10 to 27 isocenters (median 18 isocenters) was adopted for all patients.
Follow-Up Imaging and Clinical Evaluation
After GKS, all patients underwent regularly scheduled follow-up MR imaging and clinical evaluation at 6-month intervals. Clinical assessments were made of the patient's neurological status including facial nerve, trigeminal nerve, and cochlear nerve functions, as well as balance problems (brainstem or cerebellar sign). The patients' clinical statuses were classified as improved, stable, or deteriorated. Changes in tumor volume were measured on MR images as previously reported. 4 Briefly, total tumor volume was calculated by 1) multiplying the tumor area on each MR imaging slice by the interval thickness of the slice (3 mm) and 2) adding these results. Tumor responses to GKS on MR imaging studies were classified into 3 categories: 1) tumor regression (residual tumor volume < 100% of the pre-GKS tumor volume); 2) stable tumor (residual tumor volume 100%-110% of the pre-GKS volume); and 3) tumor progression (residual tumor volume > 110% of the pre-GKS tumor volume).
Statistical Analysis
We analyzed the results by performing traditional bivariate tests: independent t-test, 1-way ANOVA, and Pearson correlation. Ordered variables such as sex were analyzed by performing the chi-square test. Nonparametric tests (the Mann-Whitney U-test, Kruskal-Wallis H-test, and Spearman rank correlation) were used when conditions required by classic tests were not obviously met. Kaplan-Meier analysis was applied to assess tumor control duration in our long-term follow-up.
Results
Changes in Tumor Volume After GKS
The mean follow-up time after GKS for patients with large VSs was 66.0 months (median 53 months, range 12-155 months) ( Table 1 ). The clinical effect of radiosurgery was determined by assessing changes in tumor volume on regularly scheduled follow-up MR images. Figure 1 shows 2 typical examples of satisfactory tumor regression at 7 and 11 years after radiosurgery. Figure 3A shows that the most obvious tumor response occurred during the 1st 3 years after radiosurgery. In the 1st 2 years, stable tumor or tumor regression was observed in two-thirds of the patients. After 3 years, tumor regression was evident in 93% of patients. By 10 years after radiosurgery, tumor regression was evident in all patients. In general, most enlargements in tumor volume were found in the early follow-up period, regardless of the initial tumor size. When we compared the responses of all VSs to radiosurgery, we found that large VSs decreased in volume more rapidly than small ones (Fig. 3B) . 17 The results of the latest MR imaging studies are summarized in Table 3 ; the tumor was controlled in 18 patients (85.7%), of whom 17 harbored a tumor that had regressed in size and 1 had a tumor that remained unchanged. One patient whose tumor had progressed at 21 months after radiosurgery was closely observed, because he had no clinical symptoms of imbalance and enjoyed good daily activities. That patient had undergone partial excision of the tumor before radio- surgery. Two other patients whose tumors progressed in volume will be discussed later in Surgical Intervention.
Neurological Outcomes
The results of clinical evaluations of cranial nerve symptoms are listed in Table 3 . Most facial palsies were caused by previous operative procedures. After radiosurgery, no deterioration in facial nerve function was noted. Hearing loss or impairment was noted in 20 patients before radiosurgery. There were no obvious improvements after GKS. One patient with preoperative tinnitus experienced hearing impairment after radiosurgery. Before treatment, facial numbness was noted in 8 patients, and this symptom remained stable following GKS. In this series, 5 patients (23.8%) experienced new onset or progression of imbalance. The duration of gait disturbance was compatible with the presence of initial tumor swelling or cyst enlargement.
Surgical Intervention
During the follow-up period, 5 patients experienced tumor progression, which caused dizziness and gait disturbance. Surgical interventions were required, including VP shunt placement in 2 patients, aspiration using an Ommaya reservoir in 1 patient, and microsurgical tumor resection in 2 patients.
Two patients received VP shunts to relieve hydrocephalus caused by temporary tumor swelling at 7 and 17 months after GKS. In another patient, enlargement of cysts within the tumor developed between 2 and 11 months after GKS; an Ommaya reservoir was stereotactically placed, and the cyst was aspirated for decompression. These 3 patients recovered satisfactorily after minor procedures. Two patients underwent craniotomy because of tumor enlargement: in 1 of these patients, the tumor had enlarged 26% at 8 months, and in the other, the lesion had enlarged 324% at 72 months after GKS. The former patient experienced mild imbalance and dizziness; he underwent craniotomy and subtotal excision of the tumor at the request of his family. The second Fig. 2 . Axial T2-weighted image, obtained at the level of the internal acoustic meatus, showing a large VS with complex cystic and solid parts and a distorted brainstem. The mean signal intensity of the tumor on T2-weighted images was obtained by hand drawing the perimeter of the ROI (red line), which encompasses the whole tumor volume, slice by slice on the picture archiving and communication system (SmartI-RIS, Helpera). The signal intensity of the brainstem on T2-weighted images was obtained using a 1-cm circular ROI (bordered by the yellow line) at the center of the brainstem on the slice obtained at the internal acoustic meatus level. The normalized ratio was calculated using the following formula: T/BS T2 ratio = mean signal intensity of tumor/signal intensity of brainstem on the T2-weighted MR image. In this MR image, the T/BS T2 ratio is 2.5.
Fig. 3. Upper:
Bar graph showing the distribution of patients whose tumor volume progressed, remained stable, or regressed in size over time. In the first 2 years, there was tumor regression or stable tumor in two-thirds of the patients. After 3 years, tumor regression was found in 93% of patients. All tumors had regressed by 10 years after radiosurgery. Lower: Scatterplot showing the trend of tumor volume changes after radiosurgery for large VS. The graph shows percentages of tumor volume over time; the steep downward slope of the curve at 1-2 years after GKS represents a rapid decrease in tumor volume after an initial temporary increase. The downward slope of the curve in large VSs is steeper than that in small-and medium-sized VSs and, correspondingly, the duration of transient tumor swelling is shorter.
patient harbored a large tumor in the left cerebellopontine angle; there was bone involvement but no brainstem compression. She requested radiosurgery instead of surgery for personal reasons. The tumor remained stable for 5.5 years; however, uncontrollable tumor growth developed 72 months after radiosurgery. A diagnosis of malignant peripheral nerve sheath tumor was proven by histopathological analysis. Although this patient underwent craniotomy twice, as well as adjuvant radiation treatment, she died of disease progression 82 months after the first GKS. Detailed information on this patient has been published elsewhere. 17 In summary, in this group of patients, the tumor control rate was 93.8% at 5 years and 83.3% at 12 years, as plotted using Kaplan-Meier analysis (Fig. 4) .
Prognostic Factors Associated With Tumor Control
Many previous reports provide potential prognostic factors affecting tumor response. In our study, we tried to determine correlations between factors such as patient sex and age, initial tumor volume, prescribed radiation dose (including maximal dose, margin dose, and mean dose), presence of brainstem compression and/or bone invasion, T/BS T2 ratio, and presence of cystic or solid components in the tumor and the response of the tumor to radiosurgery with respect to changes in tumor volume (Table 4) . Only the T/BS T2 ratio seemed slightly lower in patients in whom there was tumor regression; however, this finding had no statistical significance (p = 0.08).
Prediction of the Duration of Tumor Swelling by Tumor Characteristics on MR Images
We were concerned about the duration of tumor swelling while we tried to achieve the best therapeutic radiosurgical effect. During close follow-up of patients with large VSs, we tried to decide what factor(s) affected the duration of tumor swelling. As shown in Table 5 , the mean duration of tumor swelling was 11.05 months, and the mean T/BS T2 ratio was 1.99. We divided patients into 2 groups based on the mean T/BS T2 ratio, with 1 group having values ≥ 1.99 and the other having values < 1.99. The correlation of the T/BS T2 ratio to the mean duration of tumor swelling was analyzed. The duration of swelling was shorter in tumors with a T/BS T2 ratio ≥ 1.99 than it was in tumors with a T/BS T2 ratio < 1.99 (4.5 compared with 17.9 months, respectively). Table 5 and Fig. 5 both show significant correlation between the duration of tumor swelling and the T/BS T2 ratio. A high T/BS T2 ratio seems to be associated with a shorter duration of tumor swelling.
In contrast, the presence of cystic components does not seem to be correlated with the duration of tumor swelling. In patients harboring a VS that only had a solid component, the mean duration of swelling was 5 months. In patients harboring a large VS with complex solid and cystic components, the duration of swelling was 13.21 months. Nevertheless, statistical analysis indicated that the presence of a cystic component did not significantly predict tumor swelling or the final results (p = 0.154) ( Table 6 ).
Discussion
Currently, there are 2 major treatment modalities available for VS: microsurgery and radiosurgery. The selection of treatment is mainly based on the size of the tumor and the extent of brainstem compression. In smalland medium-sized tumors (< 3 cm in diameter), radiosurgery alone may be indicated. In our series published in 2005, the long-term tumor control rate was 96.8%, dete- rioration of the trigeminal and facial nerve function was rare, preservation of hearing was > 60%, and there was no treatment-related mortality. 4 The failure rate of radiosurgery for patients with sporadic unilateral VSs was 1.58% (7 of 444 patients). 17 Among these patients, 21 patients with large VSs underwent radiosurgery within the past 17 years. The failure rate of radiosurgery for patients with large VSs was 9.52% (2 of 21 patients). Newly developed cranial neuropathy was comparable to that previously reported. Our experiences indicate that radiosurgery can achieve long-term tumor control with low incidences of morbidity and mortality and preserve cranial nerve functions in patients with large VSs.
Rationale of Management of Large VSs
A literature review shows that it well known that even the best neurosurgeons face a dilemma when selecting microsurgery to treat a large VS. In microsurgery, tumor size is an important factor in determining total removal rate, complications, and postoperative preservation of cranial nerves, including facial, trigeminal, and cochlear nerve functions. Table 7 summarizes previously published reports of microsurgery in large VSs. Samii and Matthies 21, [29] [30] [31] performed surgery in 1000 cases of VS: complete removal was achieved in 97.9% of cases, with preservation of facial nerve function in 79% of cases. Lanman et al. 15 performed surgery in 190 cases of large VSs (> 3 cm); total removal of the tumor was accomplished in 96.3% of cases with preservation of facial nerve function in up to 81% of cases. In patients with extra-large VSs (> 4 cm), Jung et al. 11 reported good surgical results in 30 patients: 73.3% total removal and 86.4% preservation of facial nerve function. More recently, Anderson et al. 1 reported on 71 patients harboring VSs > 3 cm; the total tumor removal rate was 95.8% and the rate of preservation of facial nerve function was 80%. Ideally, the best treatment for large VSs is complete tumor resection with satisfactory preservation of facial, trigeminal, and cochlear nerve functions. However, even the most experienced neurosurgeons cannot always guarantee perfect surgical results. It has been shown that the learning curve for VS microsurgery is significant; at least 5-100 cases are needed for junior neurosurgeons to attain results comparable to those attained by experienced neurosurgeons. 3, 6, 22 In the beginning of the 1990s, a number of neurosurgeons, such as Kameyama and Lownie, performed subtotal tumor removal using intracapsular decompression, hoping to attain better functional results. Their data showed a significant reverse relationship between the completeness of tumor removal and preservation of facial nerve function. 13, 19 Regardless, all efforts were focused on preservation of cranial nerve functions instead of total resection.
Three major treatment options for large VSs are currently available: microsurgical resection, stereotactic radiosurgery, or a combination of both. Each treatment option has its own benefits, risks, and limitations. Treatment decisions should be individualized and based on the patient's age, comorbidity, tumor size, cranial nerve status, signs of brainstem compression, and severity of symptoms. In general, we recommend that patients with large VSs undergo microsurgical resection as a first treatment.
The goals of microsurgical resection are 3-fold: 1) to obtain a pathological tissue diagnosis, because MR images * FU = follow-up; NS = not specified.
do not provide information about the benign or malignant nature of the tumor; 2) to decrease the mass effect quickly by removing the tumor and associated cyst; and 3) to preserve functions of cranial nerves and the brainstem. Later, we perform adjuvant stereotactic radiosurgery to treat the residual tumor and thus prevent recurrence. Lownie et al. 19 reported intracapsular removal of large VS in 11 patients; the facial nerve was preserved in 82% of patients, but 18% of the residual tumor increased in size within 2-3 years after microsurgery. A similar result was found in 19 patients treated by Kameyama and colleagues; 13 there was tumor regrowth in 53% of patients, even as late as 15 years after microsurgery. Although tumor regrowth does not happen in every case, adjuvant radiosurgery is very helpful in preventing further tumor progression. Many reports have demonstrated excellent results, with a low tumor recurrence rate after subtotal resection combined with secondary radiosurgery. 19, 23, 25, 26 In conclusion, in the era of advanced microsurgery and radiosurgery, subtotal tumor resection with adjuvant stereotactic radiosurgery seems to be the best choice to obtain good tumor control while preserving cranial nerve functions.
In patients in whom microsurgery is contraindicated, radiosurgery alone is the favored option to treat large VSs. Previously reported GKS and stereotactic radiotherapy experiences are summarized in Table 8 ; there were good tumor control rates (84%-100%), excellent preservation of facial nerve function (100% in 5 series), cochlear nerve preservation (33%-100%), and low treatment failure rates (0-12%). Our experience yielded similar results with a low morbidity rate and a high tumor control rate. Although delayed complications of radiosurgery often take many years to appear, our 10-plus-year experience has demonstrated that GKS is a safe and minimally invasive way to treat large VSs. In addition to a better quality of life, excellent preservation of function can be expected in the vast majority of cases. The chance of needing further microsurgery was < 10% during our long-term follow-up. Some authors have argued that worse clinical outcomes may be more common and more technical difficulties are encountered when microsurgery is performed after radiosurgery. The main reasons are tissue reaction and scarring from irradiation, adhesion of facial and cochlear nerves to the tumor in some patients, and radiation-associated brain edema. 26, 34 However, the goals of adjuvant microsurgery after radiosurgery were focused on intracapsular decompression and subtotal tumor removal to relieve patients' symptoms and signs. The results in our study showed no surgery-related complications or deaths. 17 Patients benefited from the advantages conferred by both microsurgery and radiosurgery.
Case Selection and Prediction of Duration of Tumor Swelling
While observing our patients with large VSs, we realized that tumor swelling was inevitable. According to the literature, possible factors contributing to tumor swelling include maximum radiation dose, margin radiation dose, the shape of the tumor, and the presence of a cyst. 33 Because of improvements in MR imaging techniques, we were able to correlate signal intensity on T2-weighted images between the tumor and brainstem. By comparing T/ BS T2 ratios, we found that the higher the ratio, the shorter the duration of tumor swelling. The possible explanation may be that the greater the compactness of tissue with- in the tumor, the longer the duration of tumor swelling. Gomez-Brouchet et al. 7 correlated the histopathological appearance of the tumor to its depiction on MR imaging. We hypothesize that a high level of tissue compactness makes reabsorption of edema and cleaning of damaged tissue by macrophages difficult. From the results of the prognostic factors associated with successful treatment, we believe that the T/BS T2 ratio may be a critical factor in pre-GKS evaluation. However, we need more patient data and a longer follow-up time to decide which large VSs can be best treated using GKS.
Conclusions
Although large size used to be considered a contraindication for radiosurgery of VSs, this treatment option plays an important role in patients who are not suitable for microsurgery and in patients who have good hearing and facial nerve function. The results of our study demonstrate that treatment of large VSs by radiosurgery is safe and beneficial. Using a margin dose of 11-14 Gy, we achieved a 90.5% long-term tumor control rate and excellent preservation of facial nerve function. Cytoreductive surgery to decrease the size of the tumor remains an important step in assisting radiosurgery to achieve successful results with little tumor swelling and few (if any) complications. Our findings indicate that radiosurgery accompanied by a minor surgical procedure may be an excellent treatment option for large and clinically challenging VSs.
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